At Oxford BioSystems, we support scientists and clinicians studying neurodegenerative and neuroimmune disorders by providing high-quality biomarker assays for use with cerebrospinal fluid and blood samples. Our range of products from a selection of leading immunoassay manufacturers includes kits designed to deliver reliable, reproducible data to support neurological research.
Neurodegenerative diseases are a group of disorders including Alzheimer’s Disease, Parkinson’s disease, Multiple Sclerosis and Amyotrophic Lateral Sclerosis (ALS), that are characterised by the progressive loss of structure respective function of neurons, including their death. As research in this field increases, more diseases are shown to have similar cellular and sub-cellular pathogenic mechanisms.
One of the key challenges in diagnosing these conditions is the high overlap of symptoms, especially those causing cognitive impairment. However, recent research has identified a number of proteins that can aid in the characterisation of neurodegenerative disease, leading to the development of assays that could help to guide both clinicians and further research in the field.
Our product range is enhanced with additional kits for the detection and quantification of biogenic amines and biomarkers involved in inflammation or dysregulation of immune activity within the nervous system.